NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

粉刺治療的全球市場

Acne Drugs: Global Markets

出版商 BCC Research 商品編碼 961088
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
粉刺治療的全球市場 Acne Drugs: Global Markets
出版日期: 2020年09月11日內容資訊: 英文 110 Pages
簡介

全球粉刺治療市場預計將從2020年的59億美元增長到2025年的79億美元,在此期間的複合年增長率為5.7%。

其中,類維生素A市場預□□計將從2020年的19億美元增長到2025年的26億美元,在此期間的複合年增長率為6.3%。

抗生素市場預計將從2020年的16億美元增長到2025年的21億美元,在此期間的複合年增長率為6.0%。

本報告調查了全球粉刺治療市場,並概述了市場,市場和技術背景,新冠狀病毒感染(COVID-19)的影響,市場動態以及市場影響。它提供了諸如影響因素分析,藥物類型,給藥途徑,分銷渠道,區域分析,競爭狀況和公司概況等信息。

目錄

第1章簡介

第2章摘要和重點

第3章市場和技術背景

  • 粉刺療法概述
  • 粉刺性痤瘡
  • 膿皰挫傷的補救措施
  • 結節性囊性挫傷藥
  • 發生的歷史
  • 監管情況
  • 美國法規

第4章COVID-19的經濟影響

  • COVID-19對世界經濟的影響
  • 與COVID-19相關的政府支出
  • COVID-19對製藥行業供應鏈的影響
  • 暫停臨床試驗
  • 對保險提供商的影響
  • 對醫療行業併購的威脅

第5章市場動態

  • 市場增長因素
  • 概述
  • 痤瘡和臉部皮膚病的患病率增加
  • 不健康的飲食習慣和生活方式
  • 擴大護膚產品的普及
  • 老年人痤瘡病例增加
  • 市場限制
  • 藥物相關的副作用
  • 痤瘡治療方案的存在
  • 市場機會
  • 低收入和中等收入國家未滿足的需求
  • 宏觀經濟指標

第6章影響市場的因素分析

  • 波特的五力模型
  • 價值鏈分析
  • 研究與開發
  • 臨床檢查
  • 製造業
  • 市場營銷和銷售
  • 售後服務

第7章按藥品類型進行的市場分析

  • 類視黃醇
  • 抗生素
  • 激素
  • 其他

第8章按管理途徑進行市場分析

  • 局部用藥
  • 口服給藥

第9章按分銷渠道進行市場分析

  • OTC
  • 處方簽

第10章按地區進行的市場分析

  • 美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 中東/非洲

第11章競爭情況

  • 世界公司排名
  • 考慮世界市場

第12章公司簡介

  • ALLERGAN
  • BAUSCH HEALTH COMPANIES INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • GALDERMA
  • GLAXOSMITHKLINE PLC
  • MYLAN N.V.
  • PFIZER INC.
  • PERRIGO
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
目錄
Product Code: PHM236A

Highlights:

The global acne drugs market should reach $7.9 billion by 2025 from $5.9 billion in 2020 at a compound annual growth rate (CAGR) of 5.7% for the forecast years, 2020 to 2025.

The retinoids segment of the global acne drugs market is expected to grow from $1.9 billion in 2020 to $2.6 billion in 2025 at a CAGR of 6.3% for the forecast years, 2020 to 2025.

The antibiotics segment of the global acne drugs market is expected to grow from $1.6 billion in 2020 to $2.1 billion in 2025 at a CAGR of 6.0% for the forecast years, 2020 to 2025.

Report Scope:

This report offers a detailed picture of the acne drugs market. It highlights the current and future market potential for acne drugs and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025 as well as key market players.

This report details market shares for acne drugs based on drug type, route of administration, distribution channel and geography. Based on drug type, the market is segmented into retinoid, antibiotic, hormonal agent and others segments. Based on route of administration, the market is segmented into topical and oral. Based on distribution channel, the market segmented into prescription based and over the counter (OTC).

By geography, the market has been segmented into North and South America, Europe, Asia-Pacific, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data have been provided for 2020 as the base year, with forecasts for 2020 through 2025. Estimated values are based on drugs manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 33 data tables and 21 additional tables
  • An overview of the global acne drugs market
  • Estimation of the market size and analyses of global market trends, with data from 2018 and 2019, estimated data for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Highlights of current and future market potential, market size, and market share analysis based on drug type, mode of administration, distribution channel and region
  • Analysis of market trends and explanation of factors driving and restraining the growth of global acne drugs market
  • Discussion on impact of coronavirus on the global economy and information on government expenditures on COVID-19
  • Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies and new product launches in the market
  • Comprehensive company profiles of major players of the industry, including Allergan, Bausch Health, Galderma, GlaxoSmithKline PLC and Pfizer Inc.

Table of Contents

Chapter 1 Introduction

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Overview of Acne Drugs
  • Comedonal
  • Papulopustular
  • Nodulocystic
  • History of Outbreaks
  • Regulatory Scenario
  • Regulations in the U.S.

Chapter 4 Economic Impact of COVID-19

  • Impact of COVID-19 on the Global Economy
  • Government Expenditures on COVID-19
  • Impact of COVID-19 on Pharma Supply Chains
  • Disruption of Clinical Trials
  • Impact on Insurance Providers
  • Impact on Health Technology Assement
  • Threat to Healthcare Acquisitions

Chapter 5 Market Dynamics

  • Market Drivers
  • Overview
  • Increasing Prevalence of Acne and Facial Skin Diseases
  • Unhealthy Eating Habits and Lifestyles Worldwide
  • Rise in Adoption of Skin Care Products
  • Growing Acne Cases in Geriatric Population
  • Market Restraints
  • Side Effects Associated with Medication
  • Presence of Alternatives for Acne Treatment
  • Market Opportunities
  • Unmet Needs in Low- and Middle-Income Countries
  • Macroeconomic Indicators

Chapter 6 Market Factor Analysis

  • Porter's Five Forces Model
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Threat of Substitutes
  • Intensity of Rivalry
  • Value Chain Analysis
  • R&D
  • Clinical Testing
  • Manufacturing
  • Marketing and Sales
  • Post-Sales Services

Chapter 7 Market Breakdown by Drug Type

  • Global Market for Acne Drugs by Drug Type
  • Retinoid
  • Market Size and Forecast
  • Antibiotics
  • Market Size and Forecast
  • Hormonal Agents
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 8 Market Breakdown by Route of Administration

  • Global Market for Acne Drugs by Route of Administration
  • Topical
  • Market Size and Forecast
  • Oral
  • Market Size and Forecast

Chapter 9 Market Breakdown by Distribution Channel

  • Global Market for Acne Drugs by Distribution Channel
  • Over-the-Counter
  • Market Size and Forecast
  • Prescription Based
  • Market Size and Forecast

Chapter 10 Market Breakdown by Region

  • Global Market for Acne Drugs by Region
  • North and South America
  • United States
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East and Africa
  • Market Size and Forecast

Chapter 11 Competitive Landscape

  • Global Company Ranking
  • Global Acne Drug Market Insights

Chapter 12 Company Profiles

  • ALLERGAN
  • BAUSCH HEALTH COMPANIES INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • GALDERMA
  • GLAXOSMITHKLINE PLC
  • MYLAN N.V.
  • PFIZER INC.
  • PERRIGO
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

List of Tables

  • Summary Table A : Global Market for Acne Drugs, by Drug Type, Through 2025
  • Summary Table B : Global Market for Acne Drugs, by Route of Administration, Through 2025
  • Table 1 : Drugs Generally Prescribed for Acne Patients
  • Table 2 : Acne Drug Categories
  • Table 3 : Interim Economic Outlook Forecasts, by Country/Region, March 2, 2021
  • Table 4 : Expenditures on COVID-19 Crisis
  • Table 5 : Disruptions of Clinical Trials Due to COVID-19, by Therapeutic Area
  • Table 6 : Global Market for Acne Drugs, by Drug Type, Through 2025
  • Table 7 : Different Types of Retinoids and their Effects
  • Table 8 : Global Market for Retinoid for Acne, by Region, Through 2025
  • Table 9 : Global Market for Antibiotics for Acne, by Region, Through 2025
  • Table 10 : Global Market for Hormonal Agents for Acne, by Region, Through 2025
  • Table 11 : Global Market for Other Drugs for Acne, by Region, Through 2025
  • Table 12 : Global Market for Acne Drugs, by Route of Administration, Through 2025
  • Table 13 : Global Market for Acne Drugs for Topical Administration, by Region, Through 2025
  • Table 14 : Global Market for Acne Drugs for Oral Administration, by Region, Through 2025
  • Table 15 : Global Market for Acne Drugs, by Distribution Channel, Through 2025
  • Table 16 : Global Market for Over-the-Counter Acne Drugs, by Region, Through 2025
  • Table 17 : Global Market for Prescription-Based Acne Drugs, by Region, Through 2025
  • Table 18 : Global Market for Acne Drugs, by Region, Through 2025
  • Table 19 : North and South American Market for Acne Drugs, by Drug Type, Through 2025
  • Table 20 : North American Market for Acne Drugs, by Country, Through 2025
  • Table 21 : European Market for Acne Drugs, by Drug Type, Through 2025
  • Table 22 : European Market for Acne Drugs, by Country, Through 2025
  • Table 23 : Asia-Pacific Market for Acne Drugs, by Drug Type, Through 2025
  • Table 24 : Asia-Pacific Market for Acne Drugs, by Country, Through 2025
  • Table 25 : Middle Eastern and African Market for Acne Drugs, by Drug Type, Through 2025
  • Table 26 : Global Company Ranking Analysis in the Market for Acne Drugs, 2019
  • Table 27 : Recent Developments in the Market for Acne Drugs
  • Table 28 : Major Manufacturing Sites of Allergan
  • Table 29 : Allergan: Financials, 2017-2019
  • Table 30 : Allergan: Product Portfolio
  • Table 31 : Allergan: Recent Developments, March 2018-April 2020
  • Table 32 : Bausch Health Companies Inc.: Financials, 2017-2019
  • Table 33 : Bausch Health Companies Inc.: Revenue, by Business Segment, 2017-2019
  • Table 34 : Bausch Health Companies Inc.: Product Portfolio
  • Table 35 : Bausch Health Companies Inc.: Recent Developments, October 2018-April 2020
  • Table 36 : F. Hoffmann-La Roche Ltd.: Financials, 2019
  • Table 37 : F. Hoffmann-La Roche Ltd.: Revenue, by Business Segment, 2016-2018
  • Table 38 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 39 : Galderma: Products Overview
  • Table 40 : Galderma: Recent Developments, April 2015-April 2020
  • Table 41 : GlaxoSmithKline PLC: Financials, 2017-2019
  • Table 42 : GlaxoSmithKline PLC: Products and Services
  • Table 43 : Mylan N.V.: Financial Performance, 2018 and 2019
  • Table 44 : Mylan N.V.: Product Portfolio
  • Table 45 : Pfizer Inc.: Financials, 2017-2019
  • Table 46 : Pfizer Inc.: Products and Services
  • Table 47 : Perrigo: Key Products
  • Table 48 : Perrigo: Financials, 2017-2019
  • Table 49 : Perrigo: Recent Developments, March 2020
  • Table 50 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
  • Table 51 : Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019
  • Table 52 : Teva Pharmaceutical Industries Ltd.: Recent Developments, August 2015-March 2020

List of Figures

  • Summary Figure A : Global Market for Acne Drugs, by Drug Type, 2018-2025
  • Summary Figure B : Global Market Shares of Acne Drugs, by Route of Administration, 2019
  • Figure 1 : Comparison of GDP Growth, by Country, 2019 and 2020
  • Figure 2 : Distribution of the Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
  • Figure 3 : Acne Vulgaris Patients, by Age Group
  • Figure 4 : Global Market Shares of Acne Drugs, by Drug Type, 2019
  • Figure 5 : Global Market for Retinoid Acne Drugs, 2019-2025
  • Figure 6 : Global Market for Retinoid for Acne, by Region, 2018-2025
  • Figure 7 : Global Market for Antibiotics for Acne, 2019-2025
  • Figure 8 : Global Market for Antibiotics for Acne, by Region, 2018-2025
  • Figure 9 : Global Market for Hormonal Agents for Acne, 2019-2025
  • Figure 10 : Global Market for Hormonal Agents for Acne, by Region, 2018-2025
  • Figure 11 : Global Market for Other Drugs for Acne, 2019-2025
  • Figure 12 : Global Market for Other Drugs for Acne, by Region, 2018-2025
  • Figure 13 : Global Market Shares of Acne Drugs, by Route of Administration, 2019
  • Figure 14 : Global Market for Acne Drugs for Topical Administration, 2019-2025
  • Figure 15 : Global Market for Acne Drugs for Topical Administration, by Region, 2018-2025
  • Figure 16 : Global Market for Acne Drugs for Oral Administration, 2019-2025
  • Figure 17 : Global Market for Acne Drugs for Oral Administration, by Region, 2018-2025
  • Figure 18 : Global Market Shares of Acne Drugs, by Distribution Channel, 2019
  • Figure 19 : Global Market for Over-the-Counter Acne Drugs, 2019-2025
  • Figure 20 : Global Market for Over-the-Counter Acne Drugs, by Region, 2018-2025
  • Figure 21 : Global Market for Prescription-Based Acne Drugs, 2019-2025
  • Figure 22 : Global Market for Prescription-Based Acne Drugs, by Region, 2018-2025
  • Figure 23 : Global Market Shares of Acne Drugs, by Region, 2019
  • Figure 24 : North and South America Market Shares of Acne Drugs, by Drug Type, 2019
  • Figure 25 : North America Market Shares of Acne Drugs, by Country, 2019
  • Figure 26 : U.S. Market for Acne Drugs, 2019-2025
  • Figure 27 : Canadian Market for Acne Drugs, 2019-2025
  • Figure 28 : European Acne Drug Market Shares, by Drug Type, 2019
  • Figure 29 : European Market Shares of Acne Drugs, by Country, 2019
  • Figure 30 : German Market for Acne Drugs, 2019-2025
  • Figure 31 : U.K. Market for Acne Drugs, 2019-2025
  • Figure 32 : French Market for Acne Drugs, 2019-2025
  • Figure 33 : Italian Market for Acne Drugs, 2019-2025
  • Figure 34 : Spanish Market for Acne Drugs, 2019-2025
  • Figure 35 : Rest of European Market for Acne Drugs, 2019-2025
  • Figure 36 : Asia-Pacific Market Shares of Acne Drugs, by Drug Type, 2019
  • Figure 37 : Asia-Pacific Market Shares of Acne Drugs, by Country, 2019
  • Figure 38 : Chinese Market for Acne Drugs, 2019-2025
  • Figure 39 : Indian Market for Acne Drugs, 2019-2025
  • Figure 40 : Japanese Market for Acne Drugs, 2019-2025
  • Figure 41 : Australian Market for Acne Drugs, 2019-2025
  • Figure 42 : South Korean Market for Acne Drugs, 2019-2025
  • Figure 43 : Rest of Asia-Pacific Market for Acne Drugs, 2019-2025
  • Figure 44 : Middle Eastern and African Market for Acne Drugs, 2019-2025
  • Figure 45 : Middle Eastern and African Market Shares of Acne Drugs, by Drug Type, 2019
  • Figure 46 : Allergan: Revenue Share, by Business Unit, 2019
  • Figure 47 : Allergan: Revenue Share, by Region, 2019
  • Figure 48 : Bausch Health Companies Inc.: Revenue Share, by Business Segment, 2019
  • Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
  • Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2019
  • Figure 51 : GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2019
  • Figure 52 : GlaxoSmithKline PLC: Revenue Share, by Region, 2019
  • Figure 53 : Mylan N.V.: Revenue Share, by Region, 2019
  • Figure 54 : Pfizer Inc.: Revenue Share, by Business Segment, 2019
  • Figure 55 : Pfizer Inc.: Revenue Share, by Region, 2019
  • Figure 56 : Perrigo: Revenue Share, by Business Segment, 2019
  • Figure 57 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019